US Stock MarketDetailed Quotes

JSPR Jasper Therapeutics

Watchlist
  • 21.840
  • +0.860+4.10%
Close Nov 21 16:00 ET
  • 21.840
  • 0.0000.00%
Post 20:01 ET
327.63MMarket Cap-4597P/E (TTM)

Jasper Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
2.72%19.89M
-10.29%15.99M
8.07%15.07M
34.50%68.86M
28.94%17.73M
52.36%19.36M
49.02%17.83M
9.15%13.95M
38.99%51.2M
13.78%13.75M
Selling and administrative expenses
20.38%5.43M
3.69%4.7M
15.26%4.77M
3.06%17.08M
-12.88%3.89M
22.46%4.51M
18.34%4.53M
-9.76%4.14M
45.19%16.57M
30.36%4.47M
-General and administrative expense
20.38%5.43M
3.69%4.7M
15.26%4.77M
3.06%17.08M
-12.88%3.89M
22.46%4.51M
18.34%4.53M
-9.76%4.14M
45.19%16.57M
30.36%4.47M
Research and development costs
-2.65%14.46M
-15.05%11.3M
5.03%10.3M
49.55%51.79M
49.05%13.84M
64.58%14.85M
63.45%13.3M
19.75%9.81M
36.21%34.63M
7.22%9.28M
Operating profit
-2.72%-19.89M
10.29%-15.99M
-8.07%-15.07M
-34.50%-68.86M
-28.94%-17.73M
-52.36%-19.36M
-49.02%-17.83M
-9.15%-13.95M
-38.99%-51.2M
-13.78%-13.75M
Net non-operating interest income expense
-10.40%1.28M
0.97%1.45M
26.46%1.39M
641.65%5.2M
254.60%1.23M
453.28%1.43M
1,460.87%1.44M
54,700.00%1.1M
701K
348K
Non-operating interest income
-10.40%1.28M
0.97%1.45M
26.46%1.39M
641.65%5.2M
254.60%1.23M
453.28%1.43M
1,460.87%1.44M
54,700.00%1.1M
--701K
--348K
Other net income (expense)
-108.31%-32K
-112.86%-40K
97.02%-42K
-106.27%-803K
-147.87%-90K
-34.30%385K
-78.80%311K
-113.33%-1.41M
106.75%12.81M
-93.78%188K
Gain on sale of security
----
----
----
-107.99%-575K
--0
----
----
-109.50%-575K
339.92%7.2M
200.00%150K
Special income (charges)
-94.01%20K
--0
97.38%-20K
-99.69%18K
-67.06%28K
-20.85%334K
-32.80%420K
-116.63%-764K
-38.29%5.73M
-97.21%85K
-Less：Restructuring and merger&acquisition
94.01%-20K
--0
-97.38%20K
99.69%-18K
67.06%-28K
20.85%-334K
32.80%-420K
116.63%764K
38.29%-5.73M
97.21%-85K
Other non- operating income (expenses)
-201.96%-52K
63.30%-40K
68.57%-22K
-113.91%-246K
-151.06%-118K
466.67%51K
-3,533.33%-109K
5.41%-70K
-43.75%-115K
---47K
Income before tax
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
Income tax
Net income
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
Net income continuous Operations
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
Minority interest income
Net income attributable to the parent company
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
Basic earnings per share
22.50%-1.24
34.01%-0.97
36.42%-1.03
40.17%-6.18
58.33%-1.5
50.00%-1.6
49.31%-1.47
-170.00%-1.62
61.60%-10.33
-50.47%-3.6
Diluted earnings per share
22.50%-1.24
34.01%-0.97
36.42%-1.03
40.17%-6.18
58.33%-1.5
50.00%-1.6
49.31%-1.47
-170.00%-1.62
61.60%-10.33
-50.47%-3.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 2.72%19.89M-10.29%15.99M8.07%15.07M34.50%68.86M28.94%17.73M52.36%19.36M49.02%17.83M9.15%13.95M38.99%51.2M13.78%13.75M
Selling and administrative expenses 20.38%5.43M3.69%4.7M15.26%4.77M3.06%17.08M-12.88%3.89M22.46%4.51M18.34%4.53M-9.76%4.14M45.19%16.57M30.36%4.47M
-General and administrative expense 20.38%5.43M3.69%4.7M15.26%4.77M3.06%17.08M-12.88%3.89M22.46%4.51M18.34%4.53M-9.76%4.14M45.19%16.57M30.36%4.47M
Research and development costs -2.65%14.46M-15.05%11.3M5.03%10.3M49.55%51.79M49.05%13.84M64.58%14.85M63.45%13.3M19.75%9.81M36.21%34.63M7.22%9.28M
Operating profit -2.72%-19.89M10.29%-15.99M-8.07%-15.07M-34.50%-68.86M-28.94%-17.73M-52.36%-19.36M-49.02%-17.83M-9.15%-13.95M-38.99%-51.2M-13.78%-13.75M
Net non-operating interest income expense -10.40%1.28M0.97%1.45M26.46%1.39M641.65%5.2M254.60%1.23M453.28%1.43M1,460.87%1.44M54,700.00%1.1M701K348K
Non-operating interest income -10.40%1.28M0.97%1.45M26.46%1.39M641.65%5.2M254.60%1.23M453.28%1.43M1,460.87%1.44M54,700.00%1.1M--701K--348K
Other net income (expense) -108.31%-32K-112.86%-40K97.02%-42K-106.27%-803K-147.87%-90K-34.30%385K-78.80%311K-113.33%-1.41M106.75%12.81M-93.78%188K
Gain on sale of security -------------107.99%-575K--0---------109.50%-575K339.92%7.2M200.00%150K
Special income (charges) -94.01%20K--097.38%-20K-99.69%18K-67.06%28K-20.85%334K-32.80%420K-116.63%-764K-38.29%5.73M-97.21%85K
-Less：Restructuring and merger&acquisition 94.01%-20K--0-97.38%20K99.69%-18K67.06%-28K20.85%-334K32.80%-420K116.63%764K38.29%-5.73M97.21%-85K
Other non- operating income (expenses) -201.96%-52K63.30%-40K68.57%-22K-113.91%-246K-151.06%-118K466.67%51K-3,533.33%-109K5.41%-70K-43.75%-115K---47K
Income before tax -6.23%-18.64M9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M
Income tax
Net income -6.23%-18.64M9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M
Net income continuous Operations -6.23%-18.64M9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M
Minority interest income
Net income attributable to the parent company -6.23%-18.64M9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -6.23%-18.64M9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M
Basic earnings per share 22.50%-1.2434.01%-0.9736.42%-1.0340.17%-6.1858.33%-1.550.00%-1.649.31%-1.47-170.00%-1.6261.60%-10.33-50.47%-3.6
Diluted earnings per share 22.50%-1.2434.01%-0.9736.42%-1.0340.17%-6.1858.33%-1.550.00%-1.649.31%-1.47-170.00%-1.6261.60%-10.33-50.47%-3.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data